This poster presents new findings demonstrating stenoparib’s unique mechanism of action to modulate the WNT/β-catenin signaling pathway and to inhibit the growth of colorectal cancer cell lines at ...

Zentalis Pharmaceuticals, Inc. announced that an abstract has been accepted for a poster presentation at the 2025 American Society of Clinical Oncology Annual Meeting, scheduled for May 30 to June 3 ...

Patient Education Tool: 6 Colorectal Cancer Screening Posters The CDC, as part of its Screen for Life: National Colorectal Cancer Action Campaign that informs men and women about the importance of ...

Meredith Hullar, principal staff scientist working with Ulrike (Riki) Peters, PhD, MPH, and Amanda Phipps, PhD, MPH, and their teams, sought to characterize connections between the microbiome and ...

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that two posters highlighting research on botensilimab (BOT), an Fc-enhanced multifunctional anti-CTLA-4 antibody, ...

Gut health plays an important role in both the development and progression of colon cancer. Diet and a balanced microbiome are important factors in reducing the risk of colon cancer. The health of the ...

TARPON SPRINGS, Fla., April 21, 2026 – Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib ...

New AACR data highlight stenoparib’s potential in colorectal cancer through WNT pathway modulation The Stenoparib-DRP® companion diagnostic is associated with enhanced overall survival in Ovarian ...